BSE Live
Jan 27, 16:01Prev. Close
207.35
Open Price
205.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 27, 15:55Prev. Close
207.16
Open Price
210.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
203.85 (1044)
| Cash Flow of Viyash Scientific (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 43.01 | -114.42 | -62.81 | -2.50 | 22.22 | |
| Net CashFlow From Operating Activities | -24.99 | -42.37 | -12.70 | 30.21 | 48.77 | |
| Net Cash Used In Investing Activities | 23.65 | -60.82 | -31.29 | -52.44 | -68.34 | |
| Net Cash Used From Financing Activities | 7.96 | 107.56 | 38.82 | 31.58 | 12.85 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.64 | 0.05 | |
| Net Inc/Dec In Cash And Cash Equivalents | 6.62 | 4.37 | -5.17 | 9.99 | -6.66 | |
| Cash And Cash Equivalents Begin of Year | 6.48 | 2.11 | 7.29 | 5.78 | 12.44 | |
| Cash And Cash Equivalents End Of Year | 13.10 | 6.48 | 2.11 | 15.77 | 5.78 |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y